Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha.
Phosphatidylinositol 3-kinase is a key step in the metabolic actions of insulin. Two amino acid substitutions have been identified in the gene for the regulatory subunit of human p85alpha, Met-326Ile, and Asn-330Asp, and the former has been associated with alterations in glucose/insulin homeostasis. When the four human p85alpha proteins were expressed in yeast, a 27% decrease occurred in the level of protein expression of p85alpha(Ile/Asp) (P = 0.03) and a 43% decrease in p85alpha(Ile/Asn) (P = 0.08) as compared with p85alpha(Met/Asp). Both p85alpha(Ile/Asp) and p85alpha(Ile/Asn) also exhibited increased binding to phospho-insulin receptor substrate-1 by 41% and 83%, respectively (P < 0.001), as compared with p85alpha(Met/Asp). The expression of p85alpha(Ile) was also slightly decreased and the binding to insulin receptor substrate-1 slightly increased in brown preadipocytes derived from p85alpha knockout mice. Both p85alpha(Met) and p85alpha(Ile) had similar effects on AKT activity and were able to reconstitute differentiation of the preadipocytes, although the triglyceride concentration in fully differentiated adipocytes and insulin-stimulated 2-deoxyglucose uptake were slightly lower than in adipocytes expressing p85alpha(Met). Thus, the Met-326Ile variant of p85alpha is functional for intracellular signaling and adipocyte differentiation but has small alterations in protein expression and activity that could play a role in modifying insulin action.
Almind
Katrine
K
Research Division, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
Delahaye
Laurent
L
Hansen
Torben
T
Van Obberghen
Emmanuel
E
Pedersen
Oluf
O
Kahn
C Ronald
CR
D017667:Adipocytes / Q000378:metabolism; D002001:Adipose Tissue, Brown / Q000166:cytology; D000818:Animals; D002417:Cattle; D003062:Codon; D018076:DNA, Complementary / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D017930:Genes, Reporter; D005947:Glucose / Q000493:pharmacokinetics; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008715:Methionine / Q000737:chemistry*; D051379:Mice; D008957:Models, Genetic; D019869:Phosphatidylinositol 3-Kinases / Q000737:chemistry*; D010766:Phosphorylation; D010957:Plasmids / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D015398:Signal Transduction; D013997:Time Factors; D014280:Triglycerides / Q000096:biosynthesis / Q000378:metabolism; D020798:Two-Hybrid System Techniques
D003062:Codon; D018076:DNA, Complementary; D007328:Insulin; D014280:Triglycerides; D008715:Methionine; D019869:Phosphatidylinositol 3-Kinases; D005947:Glucose